These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines. Robin G, Keisari Y, Slepon R, Ashkenazi S, Cohen D. Vaccine; 1999 Aug 06; 17(23-24):3109-15. PubMed ID: 10462247 [Abstract] [Full Text] [Related]
5. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes. Citiulo F, Necchi F, Mancini F, Rossi O, Aruta MG, Gasperini G, Alfini R, Rondini S, Micoli F, Rappuoli R, Saul A, Martin LB. PLoS Negl Trop Dis; 2021 Oct 06; 15(10):e0009826. PubMed ID: 34644291 [Abstract] [Full Text] [Related]
11. Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. Riddle MS, Kaminski RW, Di Paolo C, Porter CK, Gutierrez RL, Clarkson KA, Weerts HE, Duplessis C, Castellano A, Alaimo C, Paolino K, Gormley R, Gambillara Fonck V. Clin Vaccine Immunol; 2016 Dec 06; 23(12):908-917. PubMed ID: 27581434 [Abstract] [Full Text] [Related]
13. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Bélot F, Cohen D, Sansonetti PJ, Mulard LA. J Immunol; 2009 Feb 15; 182(4):2241-7. PubMed ID: 19201878 [Abstract] [Full Text] [Related]
14. Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a. Hartman AB, Van de Verg LL, Mainhart CR, Tall BD, Smith-Gill SJ. Clin Diagn Lab Immunol; 1996 Sep 15; 3(5):584-9. PubMed ID: 8877140 [Abstract] [Full Text] [Related]
15. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity. Rasolofo-Razanamparany V, Cassel-Beraud AM, Roux J, Sansonetti PJ, Phalipon A. Infect Immun; 2001 Sep 15; 69(9):5230-4. PubMed ID: 11500390 [Abstract] [Full Text] [Related]
16. Outer Membrane Vesicles Derived from Salmonella enterica Serotype Typhimurium Can Deliver Shigella flexneri 2a O-Polysaccharide Antigen To Prevent Shigella flexneri 2a Infection in Mice. Tian H, Li B, Xu T, Yu H, Chen J, Yu H, Li S, Zeng L, Huang X, Liu Q. Appl Environ Microbiol; 2021 Sep 10; 87(19):e0096821. PubMed ID: 34319809 [Abstract] [Full Text] [Related]
17. Immunogenicity of the Shigella flexneri serotype Y (SFL 124) vaccine strain expressing cloned glucosyl transferase gene of converting bacteriophage SfX. Huan PT, Taylor R, Lindberg AA, Verma NK. Microbiol Immunol; 1995 Sep 10; 39(7):467-72. PubMed ID: 8569531 [Abstract] [Full Text] [Related]
18. Regulated Delayed Shigella flexneri 2a O-antigen Synthesis in Live Recombinant Salmonella enterica Serovar Typhimurium Induces Comparable Levels of Protective Immune Responses with Constitutive Antigen Synthesis System. Su H, Liu Q, Wang S, Curtiss R, Kong Q. Theranostics; 2019 Sep 10; 9(12):3565-3579. PubMed ID: 31281498 [Abstract] [Full Text] [Related]